| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
An (Meng)
|
230.846m | 27.51% | +464.000k | Jul 17 2025 |
| 2 |
Young (Wai Po)
|
110.050m | 13.12% | — | Jan 16 2026 |
| 3 |
Li (Zhenfu)
|
42.022m | 5.01% | -885.000k | Mar 02 2026 |
| 4 |
Fidelity Management & Research Company LLC
|
39.125m | 4.66% | +5.143m | Feb 02 2026 |
| 5 |
Fidelity Management & Research (Hong Kong) Limited
|
15.867m | 1.89% | +867.797k | Mar 31 2026 |
|
1
An (Meng)
|
27.51%
230.846m
|
|
2
Young (Wai Po)
|
13.12%
110.050m
|
|
3
Li (Zhenfu)
|
5.01%
42.022m
|
|
4
Fidelity Management & Research Company LLC
|
4.66%
39.125m
|
|
5
Fidelity Management & Research (Hong Kong) Limited
|
1.89%
15.867m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 52.19% of Consun Pharmaceutical Group, with An (Meng) the biggest at 27.51%, followed by Young (Wai Po) (13.12%) and Li (Zhenfu) (5.01%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


